Ticker League

EBITDA for Zimmer Biomet Holdings (ZBH)

Latest filings through · Reported

Metric

TTM

$2.21B

YoY change

-1.5%

5Y CAGR

+17.1%

Peak year (2024)

$2.25B

EBITDA history chart for Zimmer Biomet Holdings (ZBH) from 1998 to 2025

Latest: $2.22B

EBITDA growth chart for Zimmer Biomet Holdings (ZBH) from 1998 to 2025

Latest: -1.5%

EBITDA history table for Zimmer Biomet Holdings (ZBH) from 1998 to 2025

  • 2025$2.22B-1.5%
  • 2024$2.25B+1.4%
  • 2023$2.22B+48.5%
  • 2022$1.49B-9.1%
  • 2021$1.65B+63.6%
  • 2020$1.01B-53.0%
  • 2019$2.14B+102.0%
  • 2018$1.06B-42.9%
  • 2017$1.85B+3.3%
  • 2016$1.79B+55.7%
  • 2015$1.15B-16.4%
  • 2014$1.38B-2.2%
  • 2013$1.41B-1.1%
  • 2012$1.43B+2.3%
  • 2011$1.39B+10.6%
  • 2010$1.26B-14.4%
  • 2009$1.47B+2.7%
  • 2008$1.43B+3.7%
  • 2007$1.38B+1.0%
  • 2006$1.37B+5.5%
  • 2005$1.30B+26.5%
  • 2004$1.03B+59.1%
  • 2003$644.80M+51.3%
  • 2002$426.20M+56.9%
  • 2001$271.70M-6.7%
  • 2000$291.10M+15.1%
  • 1999$253.00M+6.8%
  • 1998$237.00M—

EBITDA values are taken from Zimmer Biomet Holdings's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EBITDA at Zimmer Biomet Holdings (ZBH)

According to Zimmer Biomet Holdings's latest reported financial statements, the company's current EBITDA (TTM) is $2.21B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

The 2025 reading of Zimmer Biomet Holdings (ZBH) EBITDA is $2.22B – edged down 1.5% year-over-year.

Zimmer Biomet Holdings EBITDA compound annual growth for the 2020–2025 (5 years) window is +17.1%, with mixed annual results across the window.

Zimmer Biomet Holdings EBITDA edged down from $2.25B in 2024 to $2.22B in 2025, a 1.5% drawdown.

The highest annual EBITDA of $2.25B was reported in 2024. The lowest in the available history was $237.00M in 1998.

Zimmer Biomet Holdings EBITDA by Year

Zimmer Biomet Holdings EBITDA 2025: $2.22B

Zimmer Biomet Holdings posted EBITDA of $2.22B in 2025, edged down 1.5% below 2024.

Zimmer Biomet Holdings EBITDA 2024: $2.25B

In 2024, Zimmer Biomet Holdings reported EBITDA of $2.25B, edged up 1.4% from 2023. This figure represents the highest annual value in the available history.

Zimmer Biomet Holdings EBITDA 2023: $2.22B

Zimmer Biomet Holdings EBITDA in 2023 was $2.22B, surged 48.5% from 2022.

Zimmer Biomet Holdings EBITDA 2022: $1.49B

2022's EBITDA for Zimmer Biomet Holdings came in at $1.49B, declined 9.1% below 2021.

Zimmer Biomet Holdings EBITDA 2021: $1.65B

Zimmer Biomet Holdings EBITDA in 2021 was $1.65B.

See more financial history for Zimmer Biomet Holdings (ZBH).

Sector peers by EBITDA

Healthcare peers of Zimmer Biomet Holdings (ZBH), ranked by their latest EBITDA

Frequently asked questions

Zimmer Biomet Holdings (ZBH) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview